DELUCIA DAVID (Chief Financial Officer) reported 1 transaction at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/7/2025ACC: 0001415889-25-007455
Officer· Chief Financial Officer
Since Mar 2026
-2.33K
Net shares
Net seller
$906.75
Total sold
0
Open market trades
0B · 0S
1
Total transactions
2.33K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.33K
Price / share
$0.39
Trade value
$906.75
% of position
2.0%
3/6/2025
118.46K→116.14K
Total
Net shares
−2.33K
Net value
-$906.75
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2025 | F · Tax Withholding | −2.33K | $0.39 | $906.75 | 2.0% | 118.46K | 116.14K |
| Total | −2.33K | -$906.75 | ||||||
Derivative Transactions0
No derivative transactions reported